OABI
OABI
NASDAQ · Life Sciences Tools & Services

Omniab Inc

$1.70
+0.05 (+3.03%)
As of Feb 8, 2:02 PM ET ·
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Buy 12 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +222.4% upside
Low Target $3.95
Average Target $5.48
High Target $7.31
Current Price $1.70
Current
$1.70
Target
$5.48
$3.95 $5.48 avg $7.31
Scenario Analysis
Bear Case
$3.95
132.4%
Low target
Base Case
$5.48
+222.4%
Avg target
Bull Case
$7.31
+330.0%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$5.67
-70.0% from high
52-Week Low
$3.45
+-50.7% from low
Target vs 52W High
$5.48
-3.4% vs high
Peer Consensus — Life Sciences Tools & Services
Stock Consensus Analysts Buy % Target Upside
TMO
Thermo Fisher Scientific Inc
Strong Buy 33 82% $369.21 -32.0%
DHR
Danaher Corp
Strong Buy 31 87% $158.11 -27.0%
A
Agilent Technologies Inc
Buy 29 72% $64.69 -50.1%
IQV
Iqvia Holdings Inc
Strong Buy 30 80% $82.96 -55.8%
MTD
Mettler-Toledo International
Hold 21 43% $170.43 -87.6%
WAT
Waters Corp
Buy 25 56% $189.60 -50.3%
ILMN
Illumina Inc
Hold 26 50% $169.36 +41.5%
WST
West Pharmaceutical Services
Strong Buy 23 78% $136.24 -45.3%